BT-1718
- Generic Name
- BT-1718
BT1718 in Patients with Advanced Solid Tumours.
Phase 1
Completed
- Conditions
- Non-Small Cell Lung CancerAdvanced Solid TumoursNon-Small Cell Lung SarcomaOesophageal Cancer
- Interventions
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 72
- Registration Number
- NCT03486730
- Locations
- 🇬🇧
Addenbrookes Hospital, Cambridge, United Kingdom
🇬🇧Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom
🇬🇧Queen Elizabeth Hospital, Birmingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath